Eric dEsparbes is CFO & VP at Innoviva, Inc. (INVA). They have made 4 open-market trades across 1 company since 2016, most recently 2024-08-15.
CIK 0001080014
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| INVA | SELL | 2018-05-21 | 2018-05-22 | $14.40 | $167K | +5.3% | +3.3% | -0.1% |
| INVA | SELL | 2018-02-21 | 2018-02-22 | $16.52 | $178K | -2.5% | +1.2% | -13.0% |
| INVA | SELL | 2017-11-20 | 2017-11-22 | $13.29 | $382K | -1.9% | +4.4% | +22.0% |
| INVA | SELL · 10b5-1 | 2017-08-21 | 2017-08-22 | $12.20 | $22K | +11.3% | +7.7% | +5.1% |
| INVA | SELL · 10b5-1 | 2017-05-22 | 2017-05-23 | $11.85 | $22K | +3.5% | +5.4% | -0.2% |
| INVA | SELL · 10b5-1 | 2017-02-21 | 2017-02-22 | $12.07 | $22K | -0.4% | +10.0% | +3.5% |
| INVA | SELL · 10b5-1 | 2016-11-21 | 2016-11-22 | $10.89 | $20K | -3.9% | -1.8% | +9.7% |
| INVA | SELL | 2016-08-22 | 2016-08-23 | $11.77 | $44K | -1.6% | +1.6% | -3.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.